FUZEON (enfuvirtide, T-20). Breaking barriers or breaking the bank?

GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies

Volumn 17, Issue 3, 2003, Pages 7-8

  Sharp, Matt ^a   Camp, Rob ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ENFUVIRTIDE; GLYCOPROTEIN GP 41; PEPTIDE FRAGMENT;

ARTICLE; DRUG COST; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE;

ANTI-HIV AGENTS; DRUG COSTS; HEALTH SERVICES ACCESSIBILITY; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; PEPTIDE FRAGMENTS;

EID: 0038100552     PISSN: 10771824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)